Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05234437
Title A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors QBiotics Group Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.